Filter
820
Filtered Results: 820
Text search:
Government
of
Sierra
Leone,
World
Health
Organization
Featured
Recommendations
78
New Publications
326
Language
Document type
No document type
540
Studies & Reports
160
Guidelines
39
Manuals
34
Strategic & Response Plan
30
Situation Updates
6
Fact sheets
5
Training Material
4
Resource Platforms
1
Online Courses
1
Countries / Regions
Sierra Leone
200
Liberia
106
Global
48
Guinea
47
Africa
35
Nigeria
29
West and Central Africa
18
Ghana
15
Uganda
13
Congo, Democratic Republic of
12
Senegal
11
Burkina Faso
10
Ethiopia
10
Kenya
10
Rwanda
10
Zambia
9
Cameroon
8
Mali
7
Syria
7
Côte d’Ivoire / Ivory Coast
6
India
6
South Sudan
6
Malawi
6
East and Southern Africa
6
Nepal
5
Tanzania
5
Mozambique
5
Central African Republic
5
Yemen
5
Togo
4
Zimbabwe
4
Afghanistan
4
Benin
4
Middle East and North Africa
4
Chad
3
Gambia
3
China
3
South Africa
3
Guinea-Bissau
2
Niger
2
Pakistan
2
Germany
2
Cambodia
2
Bangladesh
2
Namibia
2
Eswatini/ Swaziland
2
Botswana
2
Mexico
2
Myanmar / Burma
2
Sri Lanka
2
South–East Asia Region
2
Palestine
2
Haiti
1
Philippines
1
Somalia
1
Jordan
1
Indonesia
1
Peru
1
Ukraine
1
Ecuador
1
Libya
1
Angola
1
Lesotho
1
Western and Central Europe
1
Venezuela
1
Eastern Europe
1
Armenia
1
Congo-Brazzaville
1
Gabon
1
Authors & Publishers
Publication Years
Category
Countries
263
Key Resources
52
Women & Child Health
43
Public Health
42
Clinical Guidelines
32
Capacity Building
9
Pharmacy & Technologies
3
Toolboxes
Ebola
170
COVID-19
61
Mental Health
43
Disability
42
Rapid Response
41
HIV
38
AMR
26
Planetary Health
24
Global Health Education
23
Caregiver
20
Conflict
18
TB
15
Refugee
14
Health Financing Toolbox
13
NTDs
9
Polio
8
Natural Hazards
6
Cholera
5
Pharmacy
5
Specific Hazards
3
Zika
2
NCDs
2
Social Ethics
1
The report summarizes the estimates of the burden of disease attributable to unsafe drinking water, sanitation, and hygiene for the year 2019 for four hea... outcomes - diarrhoea, acute respiratory infections, soil-transmitted helminthiases, and undernutrition - which are included in the reporting of the Sustainable Development Goal indicator 3.9.2. The report includes estimates at global, regional and country level for 183 WHO Member States.
For biological agents, the publication covers 11 bacteria,
fungi and viruses listed by states parties to the Biological
Weapons Convention in declarations of past offensive
research and development programmes, or considered ...
special concern for possible use in terrorism. All of these
agents can cause natural disease in humans, though with
markedly different frequency.
Prompt, effective antimalarial treatment, and supportive care can substantially reduce the rate of mortality from severe malaria. However, many children in malaria-endemic countries do not have access to h... facilities or a qualified health care provider and do not receive the necessary care in a timely fashion. Without rapid detection of danger signs and access to effective treatment, including pre-referral treatment that can be administered in the community level, many of these children with severe malaria die.
In situations where there is no immediate access to a health care facility, WHO recommends the administration of a standard dose of an effective antimalarial medicine as pre-referral treatment before referral to a facility at which complete treatment can be administered.
Rectal artesunate is the WHO-recommended pre-referral intervention in situations where artesunate injection are not feasible for children under the age of 6 years with suspected severe malaria. The intervention reduces the risk of death or permanent disability by up to 50% provided the child is referred to a health facility at which complete treatment can be administered.
This field guide is aimed at supporting the effective deployment of RAS as pre-referral treatment of suspected severe malaria in line with the WHO malaria guidelines.
The report presents current information (updated to September 2015) on candidate vaccines, therapies and medical devices for Ebola and gives an overview of completed and on-going trials.
The Transformation Agenda (TA) ushered in an ambitious reform process intended to transform the World Health Organization (WHO) into an ... that is proactive, results-driven, accountable and which meets stakeholder expectations, towards transforming and improving public health services in the African Region. It aimed to achieve a WHO that is pro-results, which optimally and creatively targets technical work as well as make operations more responsive, with greater effectiveness in both communications and partnerships. The Africa Region has been the epicentre of the human immunodeficiency virus (HIV) epidemic and it’s one of the leading causes of disease and death on the continent. The WHO, with partners, has worked tirelessly for many years to control the threat and reduce the negative impact of the disease. Since the early 2000s, significant progress has been made in the global fight against the scourge of HIV. However, the WCA subregion was falling concerningly behind ESA on several key indicators of progress. In 2016, the WHO joined UNAIDS, UNICEF and other partners in a call for a strong and urgent response to support WCA countries to develop catch-up plans to triple and fast-track ART coverage, to enable the region to catch up with ESA by the end of 2020. Implementation of a widespread test-and-treat strategy, coupled with the scale-up of differentiated service delivery (DSD) and mobilization of requisite funding, accelerated WCA’s progress towards this goal. The HIV treatment catch-up and fast-track plan has achieved its target of seeing the West and Central African region (WCA) catch up with the Eastern and Southern African region’s (ESA) antiretroviral coverage rate of 78% in 2021, albeit later than the 2020 target time frame. A 33% improvement was achieved in WCA, against 21% in ESA, between 2015–2020. WCA achieved a significant 42% increase, compared to ESA’s 23%, between 2015 and 2021, to see WCA draw level with ESA at 78%. In the Democratic Republic of the Congo (DRC) alone, progress of up to 47% was observed between 2015 and 2020, for example. In addition, 1.6 million more People Living with HIV (PLHIV) were enrolled on antiretroviral treatment (ART) between 2015 and 2020.
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the ... Health Organization (WHO), have produced important achievements in the control of human African trypanosomiasis (HAT). As a consequence, the disease was targeted for elimination as a public health problem by 2020. The Sixty-sixth World Health Assembly endorsed this goal in resolution WHA66.12 on neglected tropical diseases, adopted in 2013.
National sleeping sickness control programmes (NSSCPs) are core to progressing control of the disease and in adapting to the different epidemiological situations. The involvement of different partners, as well as the support and trust of long-term donors, has been crucial for the achievements.
The purpose of this report is to provide an overview of the issues in regulating and managing international emergency in a selection of large and s...
The Strategic Plan of Action and Budget 2016-2025 for the elimination of onchocerciasisin countries was prepared based on the above dlrective for the consideration ... IAF 18.The vision of the plan of action is to eliminate onchocerciasis in 80 percent of Africancountries. Implementation of the plan will also help strengthen health systems at community level while implementing CDI wlll help scale-up interventions agalnst other NTDs to the benefit of the wider national health systems.
DHS Further Analysis Reports No. 97
Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines and pharmaceutical products promote drug resistance and lead to loss ... confidence in health professionals, manufacturers and distributors and in health systems. In an effort to protect people’s health, the WHO Regional Director for Africa, Dr Matshidiso Moeti, has proposed a strategy aimed at strengthening National Medicine Regulatory Authorities (NMRAs) in order to ensure that only safe, good quality and effective medical products are available.
n 2015, Member States of the United Nations adopted the 2030 Agenda for Sustainable Development and its accompanying Sustainable Development Goals (SDGs), with the third goal of the agenda focusing ...
The main purpose of the meeting was to review tsetse control tools, activities and their contribution to the elimination of gHAT and the monitoring thereof. Seven endemic countries provided reports ...
January 2020 to December 2021
It is impossible to address the many complex needs of respiratory virus surveillance with a single surveillance system. Multiple systems, investigations and studies must each be fit-for-purpose to specific priority surveillance objectives, and only ...
The 2021 COVID-19 Strategic Preparedness and Response Plan (SPRP) for AFR serves as a regional guide for a holistic public health response to COVID‑19 at regional, national and sub-national levels. The 2021
SPRP:
1. Builds upon the lessons learn...
The report summarizes key global health expenditure patterns and trends, and illustrates the potential of the new database to inform thinking about financing reforms to progress towards UHC, and als...
A key purpose of the Recovery Toolkit is to support countries in the reactivation of health services which may have suffered as a result ... the emergency. These services include ongoing programmes such as immunization and vaccinations, maternal and child health services, and noncommunicable diseases.
